Both in Pharmaceuticals
Design Therapeutics vs Annexon
Over the past year DSGN returned +84.2% and ANNX returned +32.4%; their daily moves had a correlation of 0.26.
DSGN +84.2% ANNX +32.4%Growth of $1, one year, split-adjusted
| Metric | DSGN | ANNX |
|---|---|---|
| Price | $12.62 | $4.13 |
| Market cap | $789.8M | $783.0M |
| Today | +2.10% | +2.99% |
| 1 month | −16.5% | −16.9% |
| 6 months | +21.7% | −16.7% |
| Year to date | +34.5% | −17.7% |
| 1 year | +92.1% | +22.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $207.4M | $209.2M |
| Dividend yield | — | — |
| Volatility (60d) | 52.6% | 68.8% |
| Short % of float | 21.1% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).